AJP - Heart Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H1109-H1117, 2006. First published April 7, 2006; doi:10.1152/ajpheart.00024.2006
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/H1109    most recent
00024.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, B. S.
Right arrow Articles by Leenen, F. H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, B. S.
Right arrow Articles by Leenen, F. H. H.

Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar rats

Bing S. Huang, Warren J. Cheung, Hao Wang, Junhui Tan, Roselyn A. White, and Frans H. H. Leenen

Hypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Submitted 5 January 2006 ; accepted in final form 28 March 2006

Functional studies indicate that the sympathoexcitatory and pressor responses to an increase in cerebrospinal fluid (CSF) [Na+] by central infusion of Na+-rich artificial cerebrospinal fluid (aCSF) in Wistar rats are mediated in the brain by mineralocorticoid receptor (MR) activation, ouabain-like compounds (OLC), and AT1-receptor stimulation. In the present study, we examined whether increasing CSF [Na+] by intracerebroventricular infusion of Na+-rich aCSF activates MR and thereby increases OLC and components of the renin-angiotensin system in the brain. Male Wistar rats received via osmotic minipump an intracerebroventricular infusion of aCSF or Na+-rich aCSF, in some groups combined with intracerebroventricular infusion of spironolactone (100 ng/h), antibody Fab fragments (to bind OLC), or as control {gamma}-globulins. After 2 wk of infusion, resting blood pressure and heart rate were recorded, OLC and aldosterone content in the hypothalamus were assessed by a specific ELISA or radioimmunoassay, and angiotensin-converting enzyme (ACE) and AT1-receptor binding densities in various brain nuclei were measured by autoradiography using 125I-labeled 351 A and 125I-labeled ANG II. When compared with intracerebroventricular aCSF, intracerebroventricular Na+-rich aCSF increased CSF [Na+] by ~5 mmol/l, mean arterial pressure by ~20 mmHg, heart rate by ~65 beats/min, and hypothalamic content of OLC by 50% and of aldosterone by 33%. Intracerebroventricular spironolactone did not affect CSF [Na+] but blocked the Na+-rich aCSF-induced increases in blood pressure and heart rate and OLC content. Intracerebroventricular Na+-rich aCSF increased ACE and AT1-receptor-binding densities in several brain nuclei, and Fab fragments blocked these increases. These data indicate that in Wistar rats, a chronic increase in CSF [Na+] may increase hypothalamic aldosterone and activate CNS pathways involving MR, and OLC, leading to increases in AT1-receptor and ACE densities in brain areas involved in cardiovascular regulation and hypertension.

brain mineralocorticoid receptor; ouabain; angiotensin-converting enzyme; AT1-receptor



Address for reprint requests and other correspondence: F. H. H. Leenen, Hypertension Unit, Univ. of Ottawa Heart Institute, H360, 40 Ruskin St., Ottawa, Ontario, Canada K1Y 4W7 (e-mail: fleenen{at}ottawaheart.ca)




This article has been cited by other articles:


Home page
Exp PhysiolHome page
E. P. Gomez-Sanchez, C. M. Gomez-Sanchez, M. Plonczynski, and C. E. Gomez-Sanchez
Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension
Exp Physiol, January 1, 2010; 95(1): 120 - 130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Hou, S. F. Theriault, I. Dostanic-Larson, A. E. Moseley, J. B Lingrel, H. Wu, S. Dean, and J. W. Van Huysse
Enhanced pressor response to increased CSF sodium concentration and to central ANG I in heterozygous {alpha}2 Na+-K+-ATPase knockout mice
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1427 - R1438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. S. Huang, R. A. White, A. Y. Jeng, and F. H. H. Leenen
Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R994 - R1000.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Gabor and F. H. H. Leenen
Mechanisms in the PVN mediating local and central sodium-induced hypertension in Wistar rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R618 - R630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. S. Huang, R. A. White, M. Ahmad, A. Y. Jeng, and F. H. H. Leenen
Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na+ in Wistar rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R166 - R172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-H. Zhang, Y. Yu, Y.-M. Kang, S.-G. Wei, and R. B. Felder
Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1067 - H1074.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. N. Orlov and A. A. Mongin
Salt-sensing mechanisms in blood pressure regulation and hypertension
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2039 - H2053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. B. Eap, M. Bochud, R. C. Elston, P. Bovet, M. P. Maillard, J. Nussberger, L. Schild, C. Shamlaye, and M. Burnier
CYP3A5 and ABCB1 Genes Influence Blood Pressure and Response to Treatment, and Their Effect Is Modified by Salt
Hypertension, May 1, 2007; 49(5): 1007 - 1014.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.